Four AI Disruptions Forcing a Radical Rethink of Your Approach to Content
AI is completely disrupting how organizations need to think about their content, whether it is customer-facing or internal. The data reveals just how profound—and significant–this disruption has become
Pharma Content Automation
Content automation is the practice of using systems to perform repetitive tasks to create content; such as formatting, data retrieval, and document assembly. Content automation in the pharmaceutical industry is often implemented for the following reasons:
Getting Granular with eCTD v4.0
We talk a lot about the goal of enterprise content strategy for pharma: to help speed up the process of making safe, effective medicines.
What Is a Reuse Map?
A reuse map is a blueprint for planned content reuse. Planned content reuse means that you identify ahead of time exactly which pieces of content will be reused in a specific output.
MedTech: The Time is Now for Structured Content
I recently came across a great commentary in the August 2021 issue of “Pharma Technology Focus.” The article is titled, “MDR set to transform how MedTech firms approach content management,” written by Barbara Peraltor, Director of Life Science Solutions at Amplexor.
Solving the 6 Challenges of Medical Device Content
EU Medical Device Regulation (2017/745) and In Vitro Diagnostic Regulation (2017/746) went into effect in May 2021, after about a year’s delay due to COVID-19. Medical device manufacturers have known about the new regulations for years and have been working to meet these new, more stringent standards.
Is Structured Content Ready for Pharma?
I’ve had more than one conversation over the past several years about whether pharmaceutical companies were “ready” for structured content. After all, many of the benefits of structured content roll up into one key business need: scale. And scale — the ability to produce a lot of content quickly, accurately,
5 Guidelines for Writing Clinical Trial Lay Summaries
A few years ago, the EU parliament passed EU Regulation 536/2014. Article 37 mandates that the results of pharmaceutical clinical trials need to be easily read and understood. Having easy-to-read information provides more transparency and accessibility for the general public.
Buy this Book to learn exactly what it takes to deliver personalized experiences at scale.
our recent posts
Get exclusive access to Val’s thoughts and hand-picked content with our newsletter.
“*” indicates required fields
browse by topic
- Additional Resources (1)
- Artificial intelligence (25)
- Blogs (136)
- Books (1)
- Content Operations (97)
- Content strategy (19)
- Content Strategy & Personalization (53)
- eBooks (9)
- Global readiness (8)
- Knowledge management (6)
- Personalization (19)
- Pharmaceutical (34)
- Regulatory compliance (8)
- Videos (16)
- White papers (4)
- Workflow & Governance (17)
- Workplace practices (2)